![]() 世界のニコチンアミドモノヌクレオチド(NMN)販売市場レポート、競争分析と地域機会2025-2031年Global Nicotinamide Mononucleotide (NMN) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031 世界のニコチンアミドモノヌクレオチド(NMN)市場規模は、2024年に4億1800万米ドルであり、予測期間2025-2031年のCAGRは13.4%で、2031年までに9億9200万米ドルに再調整されると予測されている。 ニコチンアミド... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー世界のニコチンアミドモノヌクレオチド(NMN)市場規模は、2024年に4億1800万米ドルであり、予測期間2025-2031年のCAGRは13.4%で、2031年までに9億9200万米ドルに再調整されると予測されている。ニコチンアミドモノヌクレオチド(NMN)は、ニコチンアミドからニコチンアミドホスホリボシルトランスフェラーゼ(NAMPT)を介して生成されるNAD+生合成の中間体であり、NMNまたはニコチンアミドリボチドとも呼ばれる。近年、NMNの糖尿病、神経変性疾患、心疾患などの加齢依存性疾患の予防や診断への応用が研究され、アンチエイジングのためのバイオマーカーとして注目されている。 NMNはニコチンアミドアデニンジヌクレオチド(NAD+)の前駆体であり、細胞の代謝とエネルギー産生に重要な役割を果たしている。加齢に伴い、人体内のNAD+のレベルは徐々に低下し、その結果、細胞の代謝が弱まり、一連の老化関連疾患の引き金となる。そのため、NMNを補うことで体内のNAD+のレベルを高めることが、老化と闘い、健康を維持するための新たな方法となっている。 世界的な健康意識の一般的な向上と科学研究と技術の継続的なブレークスルーにより、NMN市場の成長の勢いは増加し続けるだろう。将来、NMN市場はバイオテクノロジー、精密医療、栄養補助食品など他の健康産業と国境を越えた深い統合を達成し、消費者のより個別化された正確な健康ニーズを満たす一連の革新的な製品とサービスモデルを生み出すだろう。 現在、ニコチンアミドモノヌクレオチド(NMN)はまだ開発段階にある。世界市場にはメーカーが少なく、特に発展途上国では消費者の認知度も低い。世界の先進国に比べると需要は低いが、発展途上国の需要は急速に伸びている。大手各社は拡張計画を打ち出し、生産拠点を増やしている。 ニコチンアミドモノヌクレオチド(NMN)の中核メーカーには、GeneHarbor、Mirailab Bioscience、Maac10 Formulas、Herbalmax、Genex Formulaなどがある。中国が最大の生産地域で、世界市場シェアの約84%を占め、次いで北米、日本となっている。ニコチンアミドモノヌクレオチドの川下用途には、健康製品、化粧品などが含まれる。世界的に、健康製品は最大の応用市場であり、健康製品の原料は2023年にニコチンアミドモノヌクレオチドの総売上高の99%を占める。 世界のニコチンアミドモノヌクレオチド(NMN)市場は、企業別、地域(国)別、タイプ別、用途別に戦略的に区分されている。本レポートは、2020-2031年の地域別、タイプ別、用途別の売上高、収益、予測に関するデータ主導の洞察を通じて、関係者が新たな機会を活用し、製品戦略を最適化し、競合他社を凌駕することを支援します。 市場区分 企業別 ジーンハーバー ハーバルマックス ジェネックス・フォーミュラ ミライラボ・バイオサイエンス マック10フォーミュラ エッフェファーム ボンタック セルフル キングダムウェイ ABAケミカル タイプ別:(優勢セグメント vs 高収益イノベーション) 含有率98%以上 含有率 <98 用途別:(コア需要ドライバー vs 新興機会) ヘルスケア製品 化粧品 その他 地域別 マクロ地域別分析:市場規模と成長予測 - 北米 - 欧州 - アジア太平洋 - 南米 - 中東・アフリカ マイクロローカル市場の深層戦略的洞察 - 競争環境:プレーヤー優位 vs ディスラプター(例:欧州のジーンハーバー) - 新たな製品動向:コンテンツ≧98%の採用 vs コンテンツ<98%のプレミアム化 - 需要サイドのダイナミクス:中国におけるヘルスケア製品の成長 vs. 北米における化粧品の可能性 - 消費者ニーズの地域化:EUの規制ハードル vs インドの価格敏感性 重点市場 北米 中国 日本 (その他の地域は顧客のニーズに応じてカスタマイズ可能) 章立て 第1章: レポートスコープ、エグゼクティブサマリー、市場進化のシナリオ(短期/中期/長期) 第2章:世界、地域、国レベルでのニコチンアミドモノヌクレオチド(NMN)市場規模および成長可能性の定量分析 第3章:メーカーの競争ベンチマーク(収益、市場シェア、M&A、R&Dフォーカス)。 第4章:タイプ別セグメンテーション分析-ブルーオーシャン市場の発掘(例:中国における含有率<98%>)。 第5章:用途別セグメンテーション分析-高成長する川下ビジネスチャンス(例:インドの化粧品)。 第6章:地域別売上高・収益内訳(企業別、タイプ別、用途別、顧客別 第7章 主要メーカープロフィール - 財務、製品ポートフォリオ、戦略的展開。 第8章:市場ダイナミクス-促進要因、阻害要因、規制の影響、リスク軽減戦略。 第9章:実用的な結論と戦略的提言 なぜこのレポートなのか? 一般的なグローバル市場レポートとは異なり、本レポートはマクロレベルの業界動向と超ローカルなオペレーションインテリジェンスを融合させ、ニコチンアミドモノヌクレオチド(NMN)のバリューチェーン全体におけるデータ主導の意思決定を支援し、以下を取り上げます: - 地域別の市場参入リスク/機会 - 地域の慣行に基づく製品ミックスの最適化 - 断片化された市場と統合された市場における競合他社の戦術 目次1 Market Overview1.1 Nicotinamide Mononucleotide (NMN) Product Scope 1.2 Nicotinamide Mononucleotide (NMN) by Type 1.2.1 Global Nicotinamide Mononucleotide (NMN) Sales by Type (2020 & 2024 & 2031) 1.2.2 Content ≥98% 1.2.3 Content <98% 1.3 Nicotinamide Mononucleotide (NMN) by Application 1.3.1 Global Nicotinamide Mononucleotide (NMN) Sales Comparison by Application (2020 & 2024 & 2031) 1.3.2 Health Care Products 1.3.3 Cosmetics 1.3.4 Others 1.4 Global Nicotinamide Mononucleotide (NMN) Market Estimates and Forecasts (2020-2031) 1.4.1 Global Nicotinamide Mononucleotide (NMN) Market Size in Value Growth Rate (2020-2031) 1.4.2 Global Nicotinamide Mononucleotide (NMN) Market Size in Volume Growth Rate (2020-2031) 1.4.3 Global Nicotinamide Mononucleotide (NMN) Price Trends (2020-2031) 1.5 Assumptions and Limitations 2 Market Size and Prospective by Region 2.1 Global Nicotinamide Mononucleotide (NMN) Market Size by Region: 2020 VS 2024 VS 2031 2.2 Global Nicotinamide Mononucleotide (NMN) Retrospective Market Scenario by Region (2020-2025) 2.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2020-2025) 2.2.2 Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2020-2025) 2.3 Global Nicotinamide Mononucleotide (NMN) Market Estimates and Forecasts by Region (2026-2031) 2.3.1 Global Nicotinamide Mononucleotide (NMN) Sales Estimates and Forecasts by Region (2026-2031) 2.3.2 Global Nicotinamide Mononucleotide (NMN) Revenue Forecast by Region (2026-2031) 2.4 Major Region and Emerging Market Analysis 2.4.1 North America Nicotinamide Mononucleotide (NMN) Market Size and Prospective (2020-2031) 2.4.2 China Nicotinamide Mononucleotide (NMN) Market Size and Prospective (2020-2031) 2.4.3 Japan Nicotinamide Mononucleotide (NMN) Market Size and Prospective (2020-2031) 3 Global Market Size by Type 3.1 Global Nicotinamide Mononucleotide (NMN) Historic Market Review by Type (2020-2025) 3.1.1 Global Nicotinamide Mononucleotide (NMN) Sales by Type (2020-2025) 3.1.2 Global Nicotinamide Mononucleotide (NMN) Revenue by Type (2020-2025) 3.1.3 Global Nicotinamide Mononucleotide (NMN) Price by Type (2020-2025) 3.2 Global Nicotinamide Mononucleotide (NMN) Market Estimates and Forecasts by Type (2026-2031) 3.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Forecast by Type (2026-2031) 3.2.2 Global Nicotinamide Mononucleotide (NMN) Revenue Forecast by Type (2026-2031) 3.2.3 Global Nicotinamide Mononucleotide (NMN) Price Forecast by Type (2026-2031) 3.3 Different Types Nicotinamide Mononucleotide (NMN) Representative Players 4 Global Market Size by Application 4.1 Global Nicotinamide Mononucleotide (NMN) Historic Market Review by Application (2020-2025) 4.1.1 Global Nicotinamide Mononucleotide (NMN) Sales by Application (2020-2025) 4.1.2 Global Nicotinamide Mononucleotide (NMN) Revenue by Application (2020-2025) 4.1.3 Global Nicotinamide Mononucleotide (NMN) Price by Application (2020-2025) 4.2 Global Nicotinamide Mononucleotide (NMN) Market Estimates and Forecasts by Application (2026-2031) 4.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Forecast by Application (2026-2031) 4.2.2 Global Nicotinamide Mononucleotide (NMN) Revenue Forecast by Application (2026-2031) 4.2.3 Global Nicotinamide Mononucleotide (NMN) Price Forecast by Application (2026-2031) 4.3 New Sources of Growth in Nicotinamide Mononucleotide (NMN) Application 5 Competition Landscape by Players 5.1 Global Nicotinamide Mononucleotide (NMN) Sales by Players (2020-2025) 5.2 Global Top Nicotinamide Mononucleotide (NMN) Players by Revenue (2020-2025) 5.3 Global Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotinamide Mononucleotide (NMN) as of 2024) 5.4 Global Nicotinamide Mononucleotide (NMN) Average Price by Company (2020-2025) 5.5 Global Key Manufacturers of Nicotinamide Mononucleotide (NMN), Manufacturing Sites & Headquarters 5.6 Global Key Manufacturers of Nicotinamide Mononucleotide (NMN), Product Type & Application 5.7 Global Key Manufacturers of Nicotinamide Mononucleotide (NMN), Date of Enter into This Industry 5.8 Manufacturers Mergers & Acquisitions, Expansion Plans 6 Region Analysis 6.1 North America Market: Players, Segments, Downstream and Major Customers 6.1.1 North America Nicotinamide Mononucleotide (NMN) Sales by Company 6.1.1.1 North America Nicotinamide Mononucleotide (NMN) Sales by Company (2020-2025) 6.1.1.2 North America Nicotinamide Mononucleotide (NMN) Revenue by Company (2020-2025) 6.1.2 North America Nicotinamide Mononucleotide (NMN) Sales Breakdown by Type (2020-2025) 6.1.3 North America Nicotinamide Mononucleotide (NMN) Sales Breakdown by Application (2020-2025) 6.1.4 North America Nicotinamide Mononucleotide (NMN) Major Customer 6.1.5 North America Market Trend and Opportunities 6.2 China Market: Players, Segments, Downstream and Major Customers 6.2.1 China Nicotinamide Mononucleotide (NMN) Sales by Company 6.2.1.1 China Nicotinamide Mononucleotide (NMN) Sales by Company (2020-2025) 6.2.1.2 China Nicotinamide Mononucleotide (NMN) Revenue by Company (2020-2025) 6.2.2 China Nicotinamide Mononucleotide (NMN) Sales Breakdown by Type (2020-2025) 6.2.3 China Nicotinamide Mononucleotide (NMN) Sales Breakdown by Application (2020-2025) 6.2.4 China Nicotinamide Mononucleotide (NMN) Major Customer 6.2.5 China Market Trend and Opportunities 6.3 Japan Market: Players, Segments, Downstream and Major Customers 6.3.1 Japan Nicotinamide Mononucleotide (NMN) Sales by Company 6.3.1.1 Japan Nicotinamide Mononucleotide (NMN) Sales by Company (2020-2025) 6.3.1.2 Japan Nicotinamide Mononucleotide (NMN) Revenue by Company (2020-2025) 6.3.2 Japan Nicotinamide Mononucleotide (NMN) Sales Breakdown by Type (2020-2025) 6.3.3 Japan Nicotinamide Mononucleotide (NMN) Sales Breakdown by Application (2020-2025) 6.3.4 Japan Nicotinamide Mononucleotide (NMN) Major Customer 6.3.5 Japan Market Trend and Opportunities 7 Company Profiles and Key Figures 7.1 GeneHarbor 7.1.1 GeneHarbor Company Information 7.1.2 GeneHarbor Business Overview 7.1.3 GeneHarbor Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025) 7.1.4 GeneHarbor Nicotinamide Mononucleotide (NMN) Products Offered 7.1.5 GeneHarbor Recent Development 7.2 Herbalmax 7.2.1 Herbalmax Company Information 7.2.2 Herbalmax Business Overview 7.2.3 Herbalmax Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025) 7.2.4 Herbalmax Nicotinamide Mononucleotide (NMN) Products Offered 7.2.5 Herbalmax Recent Development 7.3 Genex Formulas 7.3.1 Genex Formulas Company Information 7.3.2 Genex Formulas Business Overview 7.3.3 Genex Formulas Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025) 7.3.4 Genex Formulas Nicotinamide Mononucleotide (NMN) Products Offered 7.3.5 Genex Formulas Recent Development 7.4 Mirailab Bioscience 7.4.1 Mirailab Bioscience Company Information 7.4.2 Mirailab Bioscience Business Overview 7.4.3 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025) 7.4.4 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Products Offered 7.4.5 Mirailab Bioscience Recent Development 7.5 Maac10 Formulas 7.5.1 Maac10 Formulas Company Information 7.5.2 Maac10 Formulas Business Overview 7.5.3 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025) 7.5.4 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Products Offered 7.5.5 Maac10 Formulas Recent Development 7.6 EffePharm 7.6.1 EffePharm Company Information 7.6.2 EffePharm Business Overview 7.6.3 EffePharm Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025) 7.6.4 EffePharm Nicotinamide Mononucleotide (NMN) Products Offered 7.6.5 EffePharm Recent Development 7.7 Bontac 7.7.1 Bontac Company Information 7.7.2 Bontac Business Overview 7.7.3 Bontac Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025) 7.7.4 Bontac Nicotinamide Mononucleotide (NMN) Products Offered 7.7.5 Bontac Recent Development 7.8 CELFULL 7.8.1 CELFULL Company Information 7.8.2 CELFULL Business Overview 7.8.3 CELFULL Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025) 7.8.4 CELFULL Nicotinamide Mononucleotide (NMN) Products Offered 7.8.5 CELFULL Recent Development 7.9 Kingdomway 7.9.1 Kingdomway Company Information 7.9.2 Kingdomway Business Overview 7.9.3 Kingdomway Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025) 7.9.4 Kingdomway Nicotinamide Mononucleotide (NMN) Products Offered 7.9.5 Kingdomway Recent Development 7.10 ABA Chemical 7.10.1 ABA Chemical Company Information 7.10.2 ABA Chemical Business Overview 7.10.3 ABA Chemical Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025) 7.10.4 ABA Chemical Nicotinamide Mononucleotide (NMN) Products Offered 7.10.5 ABA Chemical Recent Development 8 Nicotinamide Mononucleotide (NMN) Manufacturing Cost Analysis 8.1 Nicotinamide Mononucleotide (NMN) Key Raw Materials Analysis 8.1.1 Key Raw Materials 8.1.2 Key Suppliers of Raw Materials 8.2 Proportion of Manufacturing Cost Structure 8.3 Manufacturing Process Analysis of Nicotinamide Mononucleotide (NMN) 8.4 Nicotinamide Mononucleotide (NMN) Industrial Chain Analysis 9 Marketing Channel, Distributors and Customers 9.1 Marketing Channel 9.2 Nicotinamide Mononucleotide (NMN) Distributors List 9.3 Nicotinamide Mononucleotide (NMN) Customers 10 Nicotinamide Mononucleotide (NMN) Market Dynamics 10.1 Nicotinamide Mononucleotide (NMN) Industry Trends 10.2 Nicotinamide Mononucleotide (NMN) Market Drivers 10.3 Nicotinamide Mononucleotide (NMN) Market Challenges 10.4 Nicotinamide Mononucleotide (NMN) Market Restraints 11 Research Findings and Conclusion 12 Appendix 12.1 Research Methodology 12.1.1 Methodology/Research Approach 12.1.1.1 Research Programs/Design 12.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 12.1.2 Data Source 12.1.2.1 Secondary Sources 12.1.2.2 Primary Sources 12.2 Author Details 12.3 Disclaimer
SummaryThe global Nicotinamide Mononucleotide (NMN) market size was US$ 418 million in 2024 and is forecast to a readjusted size of US$ 992 million by 2031 with a CAGR of 13.4% during the forecast period 2025-2031. Table of Contents1 Market Overview1.1 Nicotinamide Mononucleotide (NMN) Product Scope 1.2 Nicotinamide Mononucleotide (NMN) by Type 1.2.1 Global Nicotinamide Mononucleotide (NMN) Sales by Type (2020 & 2024 & 2031) 1.2.2 Content ≥98% 1.2.3 Content <98% 1.3 Nicotinamide Mononucleotide (NMN) by Application 1.3.1 Global Nicotinamide Mononucleotide (NMN) Sales Comparison by Application (2020 & 2024 & 2031) 1.3.2 Health Care Products 1.3.3 Cosmetics 1.3.4 Others 1.4 Global Nicotinamide Mononucleotide (NMN) Market Estimates and Forecasts (2020-2031) 1.4.1 Global Nicotinamide Mononucleotide (NMN) Market Size in Value Growth Rate (2020-2031) 1.4.2 Global Nicotinamide Mononucleotide (NMN) Market Size in Volume Growth Rate (2020-2031) 1.4.3 Global Nicotinamide Mononucleotide (NMN) Price Trends (2020-2031) 1.5 Assumptions and Limitations 2 Market Size and Prospective by Region 2.1 Global Nicotinamide Mononucleotide (NMN) Market Size by Region: 2020 VS 2024 VS 2031 2.2 Global Nicotinamide Mononucleotide (NMN) Retrospective Market Scenario by Region (2020-2025) 2.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2020-2025) 2.2.2 Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2020-2025) 2.3 Global Nicotinamide Mononucleotide (NMN) Market Estimates and Forecasts by Region (2026-2031) 2.3.1 Global Nicotinamide Mononucleotide (NMN) Sales Estimates and Forecasts by Region (2026-2031) 2.3.2 Global Nicotinamide Mononucleotide (NMN) Revenue Forecast by Region (2026-2031) 2.4 Major Region and Emerging Market Analysis 2.4.1 North America Nicotinamide Mononucleotide (NMN) Market Size and Prospective (2020-2031) 2.4.2 China Nicotinamide Mononucleotide (NMN) Market Size and Prospective (2020-2031) 2.4.3 Japan Nicotinamide Mononucleotide (NMN) Market Size and Prospective (2020-2031) 3 Global Market Size by Type 3.1 Global Nicotinamide Mononucleotide (NMN) Historic Market Review by Type (2020-2025) 3.1.1 Global Nicotinamide Mononucleotide (NMN) Sales by Type (2020-2025) 3.1.2 Global Nicotinamide Mononucleotide (NMN) Revenue by Type (2020-2025) 3.1.3 Global Nicotinamide Mononucleotide (NMN) Price by Type (2020-2025) 3.2 Global Nicotinamide Mononucleotide (NMN) Market Estimates and Forecasts by Type (2026-2031) 3.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Forecast by Type (2026-2031) 3.2.2 Global Nicotinamide Mononucleotide (NMN) Revenue Forecast by Type (2026-2031) 3.2.3 Global Nicotinamide Mononucleotide (NMN) Price Forecast by Type (2026-2031) 3.3 Different Types Nicotinamide Mononucleotide (NMN) Representative Players 4 Global Market Size by Application 4.1 Global Nicotinamide Mononucleotide (NMN) Historic Market Review by Application (2020-2025) 4.1.1 Global Nicotinamide Mononucleotide (NMN) Sales by Application (2020-2025) 4.1.2 Global Nicotinamide Mononucleotide (NMN) Revenue by Application (2020-2025) 4.1.3 Global Nicotinamide Mononucleotide (NMN) Price by Application (2020-2025) 4.2 Global Nicotinamide Mononucleotide (NMN) Market Estimates and Forecasts by Application (2026-2031) 4.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Forecast by Application (2026-2031) 4.2.2 Global Nicotinamide Mononucleotide (NMN) Revenue Forecast by Application (2026-2031) 4.2.3 Global Nicotinamide Mononucleotide (NMN) Price Forecast by Application (2026-2031) 4.3 New Sources of Growth in Nicotinamide Mononucleotide (NMN) Application 5 Competition Landscape by Players 5.1 Global Nicotinamide Mononucleotide (NMN) Sales by Players (2020-2025) 5.2 Global Top Nicotinamide Mononucleotide (NMN) Players by Revenue (2020-2025) 5.3 Global Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotinamide Mononucleotide (NMN) as of 2024) 5.4 Global Nicotinamide Mononucleotide (NMN) Average Price by Company (2020-2025) 5.5 Global Key Manufacturers of Nicotinamide Mononucleotide (NMN), Manufacturing Sites & Headquarters 5.6 Global Key Manufacturers of Nicotinamide Mononucleotide (NMN), Product Type & Application 5.7 Global Key Manufacturers of Nicotinamide Mononucleotide (NMN), Date of Enter into This Industry 5.8 Manufacturers Mergers & Acquisitions, Expansion Plans 6 Region Analysis 6.1 North America Market: Players, Segments, Downstream and Major Customers 6.1.1 North America Nicotinamide Mononucleotide (NMN) Sales by Company 6.1.1.1 North America Nicotinamide Mononucleotide (NMN) Sales by Company (2020-2025) 6.1.1.2 North America Nicotinamide Mononucleotide (NMN) Revenue by Company (2020-2025) 6.1.2 North America Nicotinamide Mononucleotide (NMN) Sales Breakdown by Type (2020-2025) 6.1.3 North America Nicotinamide Mononucleotide (NMN) Sales Breakdown by Application (2020-2025) 6.1.4 North America Nicotinamide Mononucleotide (NMN) Major Customer 6.1.5 North America Market Trend and Opportunities 6.2 China Market: Players, Segments, Downstream and Major Customers 6.2.1 China Nicotinamide Mononucleotide (NMN) Sales by Company 6.2.1.1 China Nicotinamide Mononucleotide (NMN) Sales by Company (2020-2025) 6.2.1.2 China Nicotinamide Mononucleotide (NMN) Revenue by Company (2020-2025) 6.2.2 China Nicotinamide Mononucleotide (NMN) Sales Breakdown by Type (2020-2025) 6.2.3 China Nicotinamide Mononucleotide (NMN) Sales Breakdown by Application (2020-2025) 6.2.4 China Nicotinamide Mononucleotide (NMN) Major Customer 6.2.5 China Market Trend and Opportunities 6.3 Japan Market: Players, Segments, Downstream and Major Customers 6.3.1 Japan Nicotinamide Mononucleotide (NMN) Sales by Company 6.3.1.1 Japan Nicotinamide Mononucleotide (NMN) Sales by Company (2020-2025) 6.3.1.2 Japan Nicotinamide Mononucleotide (NMN) Revenue by Company (2020-2025) 6.3.2 Japan Nicotinamide Mononucleotide (NMN) Sales Breakdown by Type (2020-2025) 6.3.3 Japan Nicotinamide Mononucleotide (NMN) Sales Breakdown by Application (2020-2025) 6.3.4 Japan Nicotinamide Mononucleotide (NMN) Major Customer 6.3.5 Japan Market Trend and Opportunities 7 Company Profiles and Key Figures 7.1 GeneHarbor 7.1.1 GeneHarbor Company Information 7.1.2 GeneHarbor Business Overview 7.1.3 GeneHarbor Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025) 7.1.4 GeneHarbor Nicotinamide Mononucleotide (NMN) Products Offered 7.1.5 GeneHarbor Recent Development 7.2 Herbalmax 7.2.1 Herbalmax Company Information 7.2.2 Herbalmax Business Overview 7.2.3 Herbalmax Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025) 7.2.4 Herbalmax Nicotinamide Mononucleotide (NMN) Products Offered 7.2.5 Herbalmax Recent Development 7.3 Genex Formulas 7.3.1 Genex Formulas Company Information 7.3.2 Genex Formulas Business Overview 7.3.3 Genex Formulas Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025) 7.3.4 Genex Formulas Nicotinamide Mononucleotide (NMN) Products Offered 7.3.5 Genex Formulas Recent Development 7.4 Mirailab Bioscience 7.4.1 Mirailab Bioscience Company Information 7.4.2 Mirailab Bioscience Business Overview 7.4.3 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025) 7.4.4 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Products Offered 7.4.5 Mirailab Bioscience Recent Development 7.5 Maac10 Formulas 7.5.1 Maac10 Formulas Company Information 7.5.2 Maac10 Formulas Business Overview 7.5.3 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025) 7.5.4 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Products Offered 7.5.5 Maac10 Formulas Recent Development 7.6 EffePharm 7.6.1 EffePharm Company Information 7.6.2 EffePharm Business Overview 7.6.3 EffePharm Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025) 7.6.4 EffePharm Nicotinamide Mononucleotide (NMN) Products Offered 7.6.5 EffePharm Recent Development 7.7 Bontac 7.7.1 Bontac Company Information 7.7.2 Bontac Business Overview 7.7.3 Bontac Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025) 7.7.4 Bontac Nicotinamide Mononucleotide (NMN) Products Offered 7.7.5 Bontac Recent Development 7.8 CELFULL 7.8.1 CELFULL Company Information 7.8.2 CELFULL Business Overview 7.8.3 CELFULL Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025) 7.8.4 CELFULL Nicotinamide Mononucleotide (NMN) Products Offered 7.8.5 CELFULL Recent Development 7.9 Kingdomway 7.9.1 Kingdomway Company Information 7.9.2 Kingdomway Business Overview 7.9.3 Kingdomway Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025) 7.9.4 Kingdomway Nicotinamide Mononucleotide (NMN) Products Offered 7.9.5 Kingdomway Recent Development 7.10 ABA Chemical 7.10.1 ABA Chemical Company Information 7.10.2 ABA Chemical Business Overview 7.10.3 ABA Chemical Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025) 7.10.4 ABA Chemical Nicotinamide Mononucleotide (NMN) Products Offered 7.10.5 ABA Chemical Recent Development 8 Nicotinamide Mononucleotide (NMN) Manufacturing Cost Analysis 8.1 Nicotinamide Mononucleotide (NMN) Key Raw Materials Analysis 8.1.1 Key Raw Materials 8.1.2 Key Suppliers of Raw Materials 8.2 Proportion of Manufacturing Cost Structure 8.3 Manufacturing Process Analysis of Nicotinamide Mononucleotide (NMN) 8.4 Nicotinamide Mononucleotide (NMN) Industrial Chain Analysis 9 Marketing Channel, Distributors and Customers 9.1 Marketing Channel 9.2 Nicotinamide Mononucleotide (NMN) Distributors List 9.3 Nicotinamide Mononucleotide (NMN) Customers 10 Nicotinamide Mononucleotide (NMN) Market Dynamics 10.1 Nicotinamide Mononucleotide (NMN) Industry Trends 10.2 Nicotinamide Mononucleotide (NMN) Market Drivers 10.3 Nicotinamide Mononucleotide (NMN) Market Challenges 10.4 Nicotinamide Mononucleotide (NMN) Market Restraints 11 Research Findings and Conclusion 12 Appendix 12.1 Research Methodology 12.1.1 Methodology/Research Approach 12.1.1.1 Research Programs/Design 12.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 12.1.2 Data Source 12.1.2.1 Secondary Sources 12.1.2.2 Primary Sources 12.2 Author Details 12.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(ケミカル)の最新刊レポート
QYResearch社の化学・材料分野での最新刊レポート
本レポートと同じKEY WORD(competitive analysis)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2025/04/25 10:26 144.11 円 164.02 円 194.52 円 |